Biao Wu
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
BEBT-209, a primary CDK4 selective inhibitor, for the treatment of HR+/HER2- advanced breast cancer (BECTOP1): a phase 1, multicentre, open-label study.
Journal: Breast (Edinburgh, Scotland)
Published: March 19, 2025
The application and predictive value of the weight-adjusted-waist index in BC prevalence assessment: a comprehensive statistical and machine learning analysis using NHANES data.
Journal: BMC cancer
Published: February 24, 2025
Breastfeeding and Reduced Risk of Breast Cancer: A Systematic Review and Meta-Analysis.
Journal: Computational and mathematical methods in medicine
Published: October 10, 2021
Interactions between the breast tissue microbiota and host gene regulation in nonpuerperal mastitis.
Interactions between the breast tissue microbiota and host gene regulation in nonpuerperal mastitis.
Journal: Microbes and infection
Published: September 17, 2021
LncRNA HOTAIR promotes breast cancer progression through regulating the miR-129-5p/FZD7 axis.
Journal: Cancer biomarkers : section A of Disease markers
Published: October 26, 2020
Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial.
Journal: Annals of translational medicine
Published: June 23, 2020
Large-scale reflective optical Janus color materials.
Journal: Nanotechnology
Published: February 14, 2020
Efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial.
Journal: Annals of translational medicine
Published: November 09, 2019
A randomized multicenter phase II trial of mecapegfilgrastim single administration versus granulocyte colony-stimulating growth factor on treating chemotherapy-induced neutropenia in breast cancer patients.
Journal: Annals of translational medicine
Published: June 18, 2019
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study.
Journal: Breast cancer research and treatment
Published: November 28, 2017
Role of Erbin in ErbB2-dependent breast tumor growth.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 08, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026